Dyadic International, Inc. (DYAI)
NASDAQ: DYAI · Real-Time Price · USD
0.9500
-0.0499 (-4.99%)
At close: Dec 5, 2025, 4:00 PM EST
0.9202
-0.0298 (-3.14%)
After-hours: Dec 5, 2025, 7:01 PM EST
Dyadic International Market Cap
Dyadic International has a market cap or net worth of $34.38 million as of December 5, 2025. Its market cap has decreased by -4.77% in one year.
Market Cap
34.38M
Enterprise Value
30.51M
1-Year Change
-4.77%
Ranking
Category
Stock Price
$0.95
Market Cap Chart
Since April 18, 2019, Dyadic International's market cap has decreased from $94.80M to $34.38M, a decrease of -63.74%. That is a compound annual growth rate of -14.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 34.40M | -33.59% |
| Dec 31, 2024 | 51.80M | 11.64% |
| Dec 29, 2023 | 46.40M | 32.19% |
| Dec 30, 2022 | 35.10M | -72.34% |
| Dec 31, 2021 | 126.90M | -14.20% |
| Dec 31, 2020 | 147.90M | 4.89% |
| Dec 31, 2019 | 141.00M | 48.73% |
View and export this data all the way back to 2019.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 904.62B |
| Johnson & Johnson | 486.51B |
| AbbVie | 399.57B |
| UnitedHealth Group | 299.75B |
| AstraZeneca | 280.82B |
| Novartis AG | 255.15B |
| Merck & Co. | 247.51B |
| Abbott Laboratories | 217.50B |